Cognito Therapeutics Company Profile 2024: Valuation, Funding ...

Cognito Therapeutics General Information Description. Developer of disease-modifying digital therapeutics designed to cure neurodegenerative disorders. The company's therapies use …

CouponFollow Extension

$118.25
OFF

Cognito Therapeutics Stock Price, Funding, Valuation, Revenue ...

6 days from now

Jul 2, 2024 · Funding, Valuation & Revenue. 5 Fundings. Cognito Therapeutics has raised $118.25M over 5 rounds.. Cognito Therapeutics's latest funding round was a Series B - III for …

cbinsights.com

$227
OFF

Cognito Therapeutics - Raised $227M Funding From 6 Investors

6 days from now

Oct 29, 2024 · Cognito Therapeutics has raised a total funding of $227M over 5 rounds from 6 investors. Investors include Morningside, FoundersX Ventures and 4 others. Their latest funding round was of $10.2M on Jun 18, 2024 .

tracxn.com

$73
OFF

Cognito | Company Overview & News - Forbes

6 days from now

Cognito Therapeutics, an MIT-based neurotechnology company, made headlines this year when they announced a $73 million investment into a premier therapy for Alzheimer’s.

forbes.com

$35000000
OFF

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

6 days from now

Jan 29, 2024 · Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B. Search Crunchbase. Start Free Trial . Chrome Extension ... Summary. Overview. Edit Overview …

crunchbase.com

$73
OFF

Cognito Therapeutics Raises $73M Series B To Advance

6 days from now

Mar 22, 2023 · The funding will advance Cognito’s pivotal study of its non-invasive neuromodulation device, which delivers proprietary gamma frequency light and sound …

businesswire.com

4%
OFF

Cognito Therapeutics

6 days from now

Cognito Therapeutics Announces Spectris™ Treatment Demonstrates 56.4% Reduction in Alzheimer’s Disease Dependence Score with Strong Safety Profile November 19, 2024 …

cognitotx.com

$50
OFF

Cognito Therapeutics Raises $50 Million For Alzheimer’s Treatment …

6 days from now

Jul 4, 2022 · June 28, 2022, STAT News, by Mario Aguilar - Cognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive …

foundersxventures.com

$50
OFF

Cognito Therapeutics Raises $50 Million For Alzheimer’s ... - STAT

6 days from now

Jun 28, 2022 · C ognito Therapeutics has raised $50 million in funding as it seeks to advance treatments for an elusive target: cognitive decline.. Cognito, based in Cambridge, Mass., is developing a headset ...

statnews.com

FAQs about Cognito Therapeutics Company Profile 2024: Valuation, Funding ... Coupon?

Who is the CEO of cognito health?

Mark Hostak is the CEO of Cognito Health. Where is Cognito Health headquartered? Cognito Health is headquartered in Goodyear, AZ. What industry is Cognito Health in? Cognito Health’s primary industry is Enterprise Systems (Healthcare). Is Cognito Health a private or public company? Cognito Health is a Private company. ...

Is Cognito a non-invasive neuromodulation device?

Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. ...

Can a Cognito headset help people with Alzheimer's disease?

Cognito, based in Cambridge, Mass., is developing a headset that feeds a patient light and sound to drive changes in the brains of people with Alzheimer’s disease and other neurological conditions. ...

Can a non-drug neuromodulation intervention help treat Alzheimer's & Cognito?

“A non-drug neuromodulation intervention has the potential to better address the complex nature of neurodegenerative diseases such as Alzheimer’s and Cognito is well-positioned to be a leader in this new paradigm,” said Helen Liang, Founder & Managing Partner, FoundersX Ventures. ...